Girish Aakalu
Corporate Officer/Principal chez GENOCEA BIOSCIENCES, INC.
Profil
Girish Aakalu is currently the Chief Executive Officer at Phenomic AI, Inc. since 2022 and the Chief Business Officer at Genocea Biosciences, Inc. since 2018.
Previously, he worked at Pfizer Inc. as the Executive Director, Head-Strategy & Innovation.
Dr. Aakalu completed his undergraduate degree at The Johns Hopkins University and holds graduate and doctorate degrees from the California Institute of Technology.
Postes actifs de Girish Aakalu
| Sociétés | Poste | Début |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 10/12/2018 |
Phenomic AI, Inc.
 Phenomic AI, Inc. Packaged SoftwareTechnology Services Phenomic AI, Inc. develops machine-learning technology for drug discovery. It provides application of deep learning to biological imaging screens and chemo-informatics. The company was founded by Oren Kraus and Sam Cooper and is headquartered in Toronto, Canada. | Chief Executive Officer | 01/06/2022 |
Anciens postes connus de Girish Aakalu
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Director/Board Member | - |
Formation de Girish Aakalu
| The Johns Hopkins University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Phenomic AI, Inc.
Phenomic AI, Inc. Packaged SoftwareTechnology Services Phenomic AI, Inc. develops machine-learning technology for drug discovery. It provides application of deep learning to biological imaging screens and chemo-informatics. The company was founded by Oren Kraus and Sam Cooper and is headquartered in Toronto, Canada. | Technology Services |
